OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: pharmaceutical company

As PDUFA Date Draws Near Investors Placing Bets on A.P. Pharma, Inc. (OTCBB: APPA)

Back on January 30, 2013 A.P. Pharma, Inc. (OTCBB: APPA) was trading at a 52-week high of 0.8870 due in large part to speculation that their lead product candidate for the prevention of chemotherapy-induced nausea, APF530, would manage to navigate … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , | Leave a comment

Has A.P. Pharma, Inc. (OTCBB: APPA) Done Enough to Ease FDA Concerns Over Lead Drug Candidate?

It is getting close to crunch time for A.P. Pharma, Inc. (OTCBB: APPA) as the specialty pharmaceutical company’s FDA assigned Prescription Drug User Fee Act (PDUFA) action date of March 27, 2013 is drawing near and the future of their … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , | Leave a comment

With New Information Indicating Effectiveness of Ampligen is Hemispherx Biopharma Any Closer to FDA Approval

Shareholders in Hemispherx Biopharma, Inc. (AMEX: HEB) have been waiting a considerable period of time for the specialty pharmaceutical company to deliver positive news regarding their Phase III trial involving the experimental therapeutic Ampligen. On Monday that news may have … Continue reading

Posted in AMEX, Articles | Tagged , , , , , , , , , , , | Leave a comment

With FDA Approval Now Secure What Path Will Avanir Pharmaceuticals Travel?

Four years ago Avanir Pharmaceuticals (NASDAQ: AVNR) had to swallow the bitter pill of rejection as the FDA turned down their application for Neudexta due to concerns over heart rhythm safety, as shares tumbled south many questioned whether the pharmaceutical … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , , , , | Leave a comment